TUBGCP3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.072300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.324600E-01
Normal-vs-Stage2
8.677500E-02
Normal-vs-Stage3
4.479700E-02
Normal-vs-Stage4
3.430600E-01
Stage1-vs-Stage2
4.517800E-01
Stage1-vs-Stage3
6.016300E-03
Stage1-vs-Stage4
6.580200E-01
Stage2-vs-Stage3
4.757600E-02
Stage2-vs-Stage4
8.420000E-01
Stage3-vs-Stage4
5.376400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.046100E-02
Normal-vs-AfricanAmerican
4.587800E-01
Normal-vs-Asian
7.189900E-02
Caucasian-vs-AfricanAmerican
3.088200E-01
Caucasian-vs-Asian
3.127200E-01
AfricanAmerican-vs-Asian
1.358960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.486000E-02
Normal-vs-Female
8.212300E-02
Male-vs-Female
8.326400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.436400E-01
Normal-vs-Age(41-60Yrs)
1.449370E-01
Normal-vs-Age(61-80Yrs)
6.879600E-02
Normal-vs-Age(81-100Yrs)
1.782810E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.421400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.479000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.761800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.414240E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.956200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.056000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.550300E-02
Normal-vs-Daily Drinker
4.054300E-02
Normal-vs-Weekly Drinker
1.040040E-01
Normal-vs-Occasional Drinker
2.682000E-01
Normal-vs-Social Drinker
2.634800E-01
Non Drinker-vs-Daily Drinker
8.341200E-01
Non Drinker-vs-Weekly Drinker
9.043000E-01
Non Drinker-vs-Occasional Drinker
4.641800E-02
Non Drinker-vs-Social Drinker
1.289170E-01
Daily Drinker-vs-Weekly Drinker
7.855400E-01
Daily Drinker-vs-Occasional Drinker
4.439600E-02
Daily Drinker-vs-Social Drinker
1.189170E-01
Weekly Drinker-vs-Occasional Drinker
1.466560E-01
Weekly Drinker-vs-Social Drinker
2.779800E-01
Occasional Drinker-vs-Social Drinker
7.856600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.079600E-02
Normal-vs-Grade 2
3.756600E-03
Normal-vs-Grade 3
2.035500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.495600E-01
Grade 1-vs-Grade 3
3.401000E-01
Grade 1-vs-Grade 4
4.079600E-02
Grade 2-vs-Grade 3
1.226620E-01
Grade 2-vs-Grade 4
3.756600E-03
Grade 3-vs-Grade 4
2.035500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.325500E-02
Normal-vs-NonDiabetic
6.876000E-02
Diabetic-vs-NonDiabetic
3.190400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.348030E-01
Normal-vs-NoPancreatitis
6.320200E-02
Pancreatitis-vs-NoPancreatitis
8.407800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.741600E-02
Normal-vs-N1
9.010200E-02
N0-vs-N1
9.787200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.743200E-01
Normal-vs-TP53-NonMutant
2.853400E-01
TP53-Mutant-vs-TP53-NonMutant
8.057600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
